Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology
Por um escritor misterioso
Descrição
A spectroscopic liquid biopsy for the earlier detection of multiple cancer types
Early detection of cancer
Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK
Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK - The Lancet Oncology
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer
Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology
GRAIL Study To Evaluate Multi-Cancer Early Detection Test for Medicare Population
de
por adulto (o preço varia de acordo com o tamanho do grupo)
